BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2243962)

  • 21. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
    Go KG; Kamman RL; Mooyaart EL; Heesters MA; Pruim J; Vaalburg W; Paans AM
    Neuroradiology; 1995 Apr; 37(3):198-206. PubMed ID: 7603595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors.
    Nelson SJ; Day MR; Buffone PJ; Wald LL; Budinger TF; Hawkins R; Dillon WP; Huhn S; Prados MD; Chang S; Vigneron DB
    J Comput Assist Tomogr; 1997; 21(2):183-91. PubMed ID: 9071283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
    Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
    Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.
    Peng J; Ouyang Y; Fang WD; Luo TY; Li YM; Lv FJ; Zhang ZW; Li XY
    Eur J Radiol; 2012 Dec; 81(12):4057-63. PubMed ID: 22749802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.
    Kwee SA; Coel MN; Lim J; Ko JP
    J Neuroimaging; 2004 Jul; 14(3):285-9. PubMed ID: 15228773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
    Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
    J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
    Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
    Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
    Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
    J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
    Deshmukh A; Scott JA; Palmer EL; Hochberg FH; Gruber M; Fischman AJ
    Clin Nucl Med; 1996 Sep; 21(9):720-5. PubMed ID: 8879874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.
    Levivier M; Goldman S; Pirotte B; Brucher JM; Balériaux D; Luxen A; Hildebrand J; Brotchi J
    J Neurosurg; 1995 Mar; 82(3):445-52. PubMed ID: 7861223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
    Bolo NR; Brennan KM; Jones RM; Budinger TF
    Ann N Y Acad Sci; 1987; 508():451-9. PubMed ID: 3501936
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
    González RG; Fischman AJ; Guimaraes AR; Carr CA; Stern CE; Halpern EF; Growdon JH; Rosen BR
    AJNR Am J Neuroradiol; 1995 Oct; 16(9):1763-70. PubMed ID: 8693972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.